Physician profile
Carl A Meyer
NPI 1689887416
$1,304.98
in general payments reported to CMS, 2019-2025
26 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.49 · 2020: $346 · 2021: $110 · 2022: $181 · 2023: $318 · 2024: $168 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $266.08 | 2020-2022 | |
| Abbvie INC. | $144.37 | 2021-2024 | |
| Intuitive Surgical, INC. | $92.36 | 2025 | |
| Teleflex LLC | $85.88 | 2021-2024 | Urolift |
| Endo Pharmaceuticals INC. | $82.24 | 2020-2023 | Aveed, Xiaflex |
| Neotract INC. | $74.11 | 2019-2020 | |
| Accord Healthcare, INC. | $69.07 | 2022-2023 | |
| C. R. Bard, INC. & Subsidiaries | $64.07 | 2023-2024 | Bard Urinary Drainage Bag |
| Healthtronics Stone Solutions, LLC | $60.80 | 2020 | |
| Merck Sharp & Dohme LLC | $39.10 | 2022-2023 | Lynparza, Keytruda |
| Axonics, INC. | $35.49 | 2022 | |
| Myovant Sciences INC. | $34.40 | 2021-2022 | |
| Boston Scientific Corporation | $34.17 | 2023 | Ams 700 Cxr Rte Kit |
| Sumitomo Pharma America, INC. | $32.40 | 2023-2024 | Gemtesa |
| Urogen Pharma, INC. | $31.28 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $20.76 | 2025 | Gentlecath |
| Tolmar Pharmaceuticals, INC. | $19.60 | 2022 | |
| Tolmar, INC. | $17.00 | 2024 | |
| Glaxosmithkline, LLC. | $16.58 | 2023 | Shingrix |
| Medtronic, INC. | $15.69 | 2023 | Interstim |
| C. R. Bard Foundation, INC. | $14.94 | 2019 | |
| Pfizer INC. | $14.30 | 2024 | |
| Allergan, INC. | $13.49 | 2021 | |
| Coloplast Corp | $13.34 | 2021 | |
| Laborie Medical Technologies Corp. | $10.31 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $3.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.